ImprimisRx PA, Inc.
https://www.imprimisrx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From ImprimisRx PA, Inc.
Finance Watch: Turnstone Biologics Launches 14th Biopharma IPO Of 2023
Turnstone’s initial public offering comes just one week after Apogee and Sagimet launched US IPOs. Also, Westlake Village BioPartners raised $450m for its third venture capital fund and argenx grossed $1.27bn in a post-Phase III follow-on offering.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Other Names / Subsidiaries
-
- Harrow Health, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice